TP53 and cancer: Conventional type of CRC is a genetic disease, and genomic mutations are the most frequent among human cancers [2]; mutations of APC (Adenomatous polyposis coli), K-ras, and TP53 (Tumor protein p53) are uniquely frequent in 81%, 43%, and 60%, respectively, by new generation sequence (NGS).